Abstract:Xu-Dong Shen, 1 Hua-Sheng Zhang, 1 Rui Zhang, 1 Jun Li, 1 Zhi-Gang Zhou, 1 Zhi-Xian Jin, 2 Yin-Jia Wang 1 1 Department of Critical Care Medicine, Calmette Hospital Affiliated to Kunming Medical University, Kunming, 650011, People's Republic of China; 2 Department of Respiratory Medicine, Calmette Hospital Affiliated to Kunming Medical University, Kunming, 650011, People's Republic of China Correspondence: Yin-Jia Wang, Department of Critical Care Medicine, Calmette Hospital Affiliated to Kunming Medical University, No. 1228 of Beijing Road, Panlong District, Kunming, 650011, People's Republic of China, Tel +86 15877990372, Fax +86 10 6666666 ; +871-67390508, Email Myocardial inhibition is the main cause of death in patients with sepsis.In recent years, methodological differences in the diagnosis, assessment, and treatment of septic myocardial depression have been observed, and how to objectively and accurately evaluate the degree of myocardial depression and the timing of treatment strategies have generally been the focus of this area of research. Based on the relevant research at home and abroad, the current review summarizes the clinical characteristics, methodological diagnosis, and symptomatic treatment of septic myocardial depression. The aim of doing so is to provide a reference for the early identification and treatment of patients with sepsis and myocardial depression. Keywords: sepsis, myocardial depression, left ventricular systolic function, fluid resuscitation Sepsis is a systemic inflammatory reaction caused by infection, 1,2 and its continued progression may lead to severe sepsis, septic shock, and even death. Cardiovascular failure caused by myocardial depression is the main cause of death in patients with sepsis. 3,4 Myocardial depression occurs in approximately 50% of patients with sepsis; compared with patients with normal cardiac function, the mortality of those with myocardial depression increases by 20%. Its risk factors of SIMD include younger age, a history of diabetes mellitus or heart failure, elevated NT pro-BNP, and positive result of blood culture, and a reduced EF < 30%. 5 Its pathophysiology is on the basis of myocardial contractile dysfunction. The myocardial contractile dysfunction is caused by microcirculatory dysfunction and autonomic dysregulation, like secretion of inflammatory cytokines and metabolism of nitric oxide. 6 Although there's no approved guidelines, myocardial depression in patients with sepsis must be detected in time and active treatment measures must be implemented to reduce the mortality caused by sepsis and improve patient prognosis. Several treatments of sepsis, such as transfusion, anti-inflammatory drugs like corticosteroid, vasopressors, can relieve the symptoms of SIMD to some extent. 6 This review summarizes the process of diagnosing and treating myocardial depression in the presence of sepsis. Approximately 50% of patients with septic shock have a significantly lower left ventricular ejection fraction (LVEF). Most patients who survive the treatment have significant left ventricular enlargement, accompanied by an increased ventricular volume at the end of diastolic and systolic phases, a normal stroke volume, low peripheral vascular resistance, and a high cardiac index. Patients who subsequently died had lower peripheral vascular resistance, a normal or high LVEF, a higher cardiac index, and normal ventricular and stroke volume, respectively. 7 Myocardial depression can occur in the very early stages of sepsis. In most patients, it occurs in the first three days following the onset of sepsis, and cardiac function essentially recovers in 7–10 days. The structure and function of the heart's right ventricle are similar to that of the left. Surviving patients may have a significant decrease in right ventricular ejection fraction (RVEF) and acute right ventricular dilatation in the early stage before gradually recovering. In patients who subsequently die, the RVEF and right ventricular end-diastolic volume may not change. 8 In addition to systolic dysfunction, in patients with sepsis-induced myocardial dysfunction (SIMD), an abnormal diastolic function may also be observed. The advent of echocardiography has enabled convenient conditions for better study of the cardiac system's diastolic phase. One study revealed that approximately 1/5 patients with SIMD experienced diastolic dysfunction and another 1/5 had both systolic and diastolic dysfunction. 9 In a prospective study conducted by Mariana et al, 10 echocardiographic investigation found that 20–60% of SIMD patients experienced a transient and reversible decline in ventricular diastolic function accompanied by sys -Abstract Truncated-

Circadian disruption on the susceptibility to sepsis-induced cardiac dysfunction: a prospective multi-modal imaging study

The Correlation Between Whole Blood Copper and Zinc Levels and Sepsis-Induced Left Ventricular Systolic Dysfunction (SILVSD) in Patients with Septic Shock: A Single-Center Prospective Observational Study

Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients.

Sirt3 is a Novel Target to Treat Sepsis Induced Myocardial Dysfunction by Acetylated Modulation of Critical Enzymes Within Cardiac Tricarboxylic Acid Cycle

Identifying predictors and determining mortality rates of septic cardiomyopathy and sepsis-related cardiogenic shock: A retrospective, observational study

[Impacts of Sepsis-Induced Myocardial Dysfunction on Hemodynamics, Organ Function and Prognosis in Patients with Septic Shock].

Cardiac dysfunction and circulating cardiac markers during sepsis

Circulating Nucleosomes As a Predictor of Sepsis and Organ Dysfunction in Critically Ill Patients.

Septic cardiomyopathy phenotype in the critically ill may depend on antimicrobial resistance

Disruption of Calcium Homeostasis in Cardiomyocytes Underlies Cardiac Structural and Functional Changes in Severe Sepsis

Types of Septic Cardiomyopathy: Prognosis and Influencing Factors - A Clinical Study

Research Progress on the Mechanism of Sepsis Induced Myocardial Injury

Characterization of critically ill patients with septic shock and sepsis-associated cardiomyopathy using cardiovascular MRI

A multicenter prospective cohort study of cardiac ultrasound phenotypes in patients with sepsis: Study protocol for a multicenter prospective cohort trial

Melatonin, clock genes and mitochondria in sepsis

Single-cell RNA sequencing reveals cell–cell communication and potential biomarker in sepsis and septic shock patients

Progress in the Clinical Assessment and Treatment of Myocardial Depression in Critically Ill Patient with Sepsis

Association Between Gut Dysbiosis and Sepsis-Induced Myocardial Dysfunction in Patients With Sepsis or Septic Shock

The Circulating CDC42 Expression in Sepsis: Relation to Disease Susceptibility, Inflammation, Multiple Organ Dysfunctions and Mortality Risk

Serial changes in left ventricular myocardial deformation in sepsis or septic shock using three-dimensional and two-dimensional speckle tracking echocardiography

Aspects of the formation of encephalopathy and myocardiopathy in sepsis